Skip to main navigation Skip to search Skip to main content

Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases

  • Edward G. McIver
  • , Justin Bryans
  • , Kristian Birchall
  • , Jasveen Chugh
  • , Thomas Drake
  • , Stephen J. Lewis
  • , Joanne Osborne
  • , Ela Smiljanic-Hurley
  • , William Tsang
  • , Ahmad Kamal
  • , Alison Levy
  • , Michelle Newman
  • , Debra Taylor
  • , J. Simon C. Arthur
  • , Kristopher Clark
  • , Philip Cohen

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclopropyl pyrimidines is described. Starting from BX795, originally reported to be a potent inhibitor of PDK1, we have developed compounds with improved selectivity and drug-like properties. These compounds have been evaluated in a range of cellular and in vivo assays, enabling us to probe the putative role of the TBK1/IKKe pathway in inflammatory diseases.

    Original languageEnglish
    Pages (from-to)7169-7173
    Number of pages5
    JournalBioorganic & Medicinal Chemistry Letters
    Volume22
    Issue number23
    DOIs
    Publication statusPublished - Dec 2012

    Fingerprint

    Dive into the research topics of 'Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKε kinases'. Together they form a unique fingerprint.

    Cite this